| Latest Forum Topics / SAM Holdings Last:0.03 -- |
|
|
Malaysia VS SG - The Reality Hard Facts !
|
|||||
|
WILLIAM.D
Member |
10-Jul-2024 12:52
|
||||
|
x 0
x 0 Alert Admin |
CBBSA hold SAM share by placement or original share ? how do u knew their cost ? bro
|
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
11-Jun-2024 09:54
|
||||
|
x 0
x 0 Alert Admin |
SAM Holdings partners with Australia-based EnGeneIC to bring latest cancer treatment innovation to Singapore
 
Catalist-listed Singapore Institute of Advanced Medicine Holdings (SAM Holdings) has entered into a strategic partnership with Australia-based biopharmaceutical company EnGeneIC.
 
Under the partnership, SAM Holdings will collaborate with EnGeneIC on a profit-sharing basis for manufacturing and distribution of anti-cancer products based on the latter&rsquo s proprietary technology platform, EnGeneIC Dream Vector (EDV). The partnership will also involve the development of EDV-based theranostics for use in the imaging and treatment of various cancers.
 
Among others, SAM Holdings will help EnGeneIC secure funding and regulatory authorisations for building a manufacturing plant in Singapore to manufacture EDV-based products and conduct clinical trials in the city-state. In turn, SAM Holdings will be granted exclusive distribution and marketing rights of these products in 17 countries within Asia. 
 
SAM Holdings will also collaborate with EnGeneIC for pre-clinical testing of EDV-based theranostics as well as obtain the regulatory approval for its commercialisation and sale. Subsequently, the company will be granted exclusive distribution rights worldwide for EDV-based theranostics.
 
&ldquo We have always been committed to providing our patients with easier access to the latest cancer treatment technologies and our partnership with EnGeneIC is another step forward in that direction,&rdquo says SAM Holdings executive director, CEO and founder Dr Djeng Shih Kien.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
SmallSmall
Supreme |
01-Mar-2024 10:38
|
||||
|
x 0
x 0 Alert Admin |
Lots of gaps to cover after it crashed from first day IPO of $0.23. Hope to see at least $0.15 with more insiders buying. |
||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
29-Feb-2024 20:49
|
||||
|
x 0
x 0 Alert Admin |
Insider (director) bought 700,000 shares thre last few day. Watch for the revenge rebound soon :) 
|
||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
29-Feb-2024 15:14
|
||||
|
x 0
x 0 Alert Admin |
The Board wishes to announce that CBBSA has sold an additional aggregate of 1,170,000 SIAMH Shares, representing approximately 0.12% of the issued and paid-up capital of SIAMH (the &ldquo Additional Sale Shares&rdquo ), through a series of open market transactions of 471,900, 398,000 and 300,100 SIAMH Shares on 26, 27 and 28 February 2024, respectively (the &ldquo Additional Disposal&rdquo ), at a volume weighted average sale price of S$0.097 per Additional Sale Share. The net proceeds received by CBBSA in cash for the Disposal and Additional Disposal (after deducting brokerage, commission, applicable goods and services tax and other related expenses) are approximately S$1,045,000 and S$113,000 respectively. Subsequent to the Additional Disposal, CBBSA no longer holds any shares in SIAMH.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
SmallSmall
Supreme |
28-Feb-2024 12:36
|
||||
|
x 1
x 0 Alert Admin |
Watch for Clearbridge to announce their last remaining sales of 900+K shares. Hopefully the rebound will be historical also. | ||||
| Useful To Me Not Useful To Me | |||||
|
Newbornborn
Veteran |
26-Feb-2024 19:37
|
||||
|
x 0
x 0 Alert Admin |
Made a history in SGX IPO.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Stocky901
Supreme |
26-Feb-2024 18:53
|
||||
|
x 0
x 0 Alert Admin |
Everyday new low. Wonder when will it stop dropping..🥺
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Newbornborn
Veteran |
26-Feb-2024 18:39
|
||||
|
x 0
x 0 Alert Admin |
Laugeable and unbelievable drop price since IPO.
|
||||
| Useful To Me Not Useful To Me | |||||
|
Stocky901
Supreme |
23-Feb-2024 10:31
|
||||
|
x 0
x 0 Alert Admin |
Why this IPO no locking periods.. ? Really a joke 😔
|
||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
23-Feb-2024 09:11
|
||||
|
x 0
x 0 Alert Admin |
Now you know why this IPO $0.23 fared so badly. Clearbridge dumped 4 mil + from day 1. Their cost is $0.115. IPO dropped 50% in 4 days.  Expected a technical rebound because 2 insiders have bought shares from open market liao. DISPOSAL OF SHARES IN SINGAPORE INSTITUTE OF ADVANCED MEDICINE HOLDINGS LIMITED 1. BACKGROUND 1.1 Disposal of Shares in Singapore Institute of Advanced Medicine Holdings Limited The board of directors (" Board" or " Directors" ) of Clearbridge Health Limited (the " Company" and together with its subsidiaries, the " Group" ) wishes to announce that Clearbridge BSA Pte. Ltd. (" CBBSA" ), a wholly-owned subsidiary of the Company, has sold an aggregate of 4,397,500 ordinary shares in the capital of Singapore Institute of Advanced Medicine Holdings Limited (" SIAMH" ), representing approximately 0.44% of the issued and paid-up capital of SIAMH (the &ldquo Sale Shares&rdquo and ordinary shares of SIAMH, &ldquo SIAMH Shares&rdquo ), through a series of open market transactions of 3,381,000, 794,900 and 221,600 SIAMH Shares on 16, 19 and 20 February 2024, respectively (the " Disposal" ), at a volume weighted average sale price of S$0.184 per Sale Share. The aggregate consideration received by CBBSA in cash for the Disposal (after deducting brokerage, commission, applicable goods and services tax and other related expenses) is approximately S$806,000 (the " Consideration" ). Subsequent to the Disposal, CBBSA holds 3,102,500 SIAMH Shares (the &ldquo Remaining Shares&rdquo ), amounting to approximately 0.31% of the issued and paid-up capital of SIAMH as at the close of business on 20 February 2024 |
||||
| Useful To Me Not Useful To Me | |||||
|
shk363
Elite |
21-Feb-2024 17:21
|
||||
|
x 0
x 0 Alert Admin |
Queue at $0.10 tikam tikam
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Stocky901
Supreme |
21-Feb-2024 17:12
|
||||
|
x 0
x 0 Alert Admin |
Closed at 0.128. a real SGX joke..🤡 🤡
|
||||
| Useful To Me Not Useful To Me | |||||
|
Stocky901
Supreme |
21-Feb-2024 16:35
|
||||
|
x 0
x 0 Alert Admin |
IPO oversubscribed.. now 0.135 Vs IPO price 0.230..🤨 🤨
|
||||
| Useful To Me Not Useful To Me | |||||
|
Stocky901
Supreme |
19-Feb-2024 15:10
|
||||
|
x 0
x 0 Alert Admin |
Nav only 10c +. IPO overpriced.. more rooms to drop..😕
|
||||
| Useful To Me Not Useful To Me | |||||
|
huattuatua
Elite |
16-Feb-2024 10:34
|
||||
|
x 0
x 0 Alert Admin |
when u read their prospectus, its been making losses for very long already, how to invest?
|
||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
16-Feb-2024 10:21
|
||||
|
x 0
x 0 Alert Admin |
Should at least go nearer to $0.20 lah....quite shameful for SGX
|
||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
16-Feb-2024 10:19
|
||||
|
x 0
x 0 Alert Admin |
IPO Price $0.23. Now $0.19 First day.... Part of Berjaya Group Malaysia. For Immediate Release Singapore Institute of Advanced Medicine Holdings Ltd&rsquo s IPO garners strong support from investors Placement Shares under the Invitation were fully subscribed for Public Offer Shares was approximately 1.39 times subscribed Gross proceeds of approximately S$26.2 million raised through the Invitation Trading of SAM Holdings&rsquo shares to commence at 9:00 a.m. (Singapore Time) on 16 February 2024 under the ticker &ldquo 9G2&rdquo on the Catalist Board of the SGXST Singapore, 15 February 2024 &ndash Singapore Institute of Advanced Medicine Holdings Ltd. (&ldquo SAM Holdings&rdquo or the &ldquo Company&rdquo , and together with its subsidiaries, the &ldquo Group&rdquo ), which aims to become a comprehensive one-stop ambulatory cancer centre, is pleased to announce that it has received strong support for its initial public offering (&ldquo IPO&rdquo ) and its Invitation Shares are fully subscribed. Following the close of the Application List in Singapore at 12.00 noon (Singapore time) on 14 February 2024, the Board of Directors of the Company (the &ldquo Board&rdquo ) is pleased to announce the following: The Placement was fully subscribed for. As at the close of the Application List in Singapore at 12.00 noon (Singapore time) on 14 February 2024, there were 286 valid applications made by way of Application Forms or Electronic Applications for an aggregate of 6,141,000 Public Offer Shares. Based on the 4,415,000 Invitation Shares available to the public for subscription, the Public Offer was approximately 1.39 times subscribed. Based on the aggregate number of 114,000,000 Invitation Shares under the Invitation, the valid applications received under the Public Offer as at the close of the Invitation and the aggregate valid applications received under the Placement, the Invitation was approximately 1.01 times subscribed. Taking into consideration the valid applications for the Invitation Shares, PrimePartners Corporate Finance Pte. Ltd., the Sponsor, Issue Manager, Underwriter and Placement Agent, in consultation with the Company, has decided that the aggregate number of 114,000,000 Invitation Shares will be re-allocated as follows: Page 2 of 4 Singapore Institute of Advanced Medicine Holdings Ltd.    1 Biopolis Drive #02‐ 01 Amnios Singapore 138622 109,126,000 Invitation Shares pursuant to the Placement and 4,874,000 Invitation Shares pursuant to the Public Offer. Trading of SAM Holdings&rsquo shares is expected to commence at 9.00 a.m. (Singapore time) on 16 February 2024, subject to the SGX-ST being satisfied that all conditions necessary for commencement of trading in the Shares on a &ldquo ready&rdquo basis have been fulfilled. Dr Djeng Shih Kien, the Executive Director and CEO, and founder of SAM Holdings, said, &ldquo As we embark on this journey, fueled by the success of our IPO, we believe that our subscription is not just a testament to our past achievements, but a vote of confidence for the growth and impact yet to come. We aim to help our patients achieve better outcomes and better quality of life. The team is excited for a future where innovation, compassion, and collaboration converge in this fight against cancer.&rdquo The Board wishes to thank all applicants who have applied for the Invitation Shares, the relevant authorities and all who have helped in one way or another in the Company&rsquo s IPO, for their support and assistance.    |
||||
| Useful To Me Not Useful To Me | |||||

